Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.1650
+0.0050 (3.13%)
Jul 31, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 98.01 million as of July 31, 2026. Its market cap has decreased by -35.95% in one year.
Market Cap
98.01M
Enterprise Value
92.65M
Revenue
8.45K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
ChartMarket Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 98.01M, an increase of 202.45%. That is a compound annual growth rate of 10.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 98.01M | -32.73% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dimerix | 144.10M |
| Actinogen Medical | 142.66M |
| Nyrada | 133.32M |
| Island Pharmaceuticals | 112.45M |
| Alterity Therapeutics | 110.93M |
| Recce Pharmaceuticals | 109.31M |
| Prescient Therapeutics | 85.17M |
| LTR Pharma | 82.71M |